SCHEDULE 13G

Company

Eloxx Pharmaceuticals, Inc.

Filed

March 20, 2015

Accession Number

0001415889-15-000983

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →